{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:16:49Z","timestamp":1788491809831,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.fertnstert.2017.07.1165","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T13:46:03Z","timestamp":1505137563000},"page":"798-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Ethinylestradiol 20\u00a0\u03bcg\/drospirenone 3\u00a0mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial"],"prefix":"10.1016","volume":"108","author":[{"given":"Tasuku","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Elliesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8550-1178","authenticated-orcid":false,"given":"Makoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Momoeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.07.1165_bib1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/humupd\/dmt016","article-title":"Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review","volume":"19","author":"Janssen","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1517\/14656566.2015.1085510","article-title":"Advances in pharmacotherapy for treating endometriosis","volume":"16","author":"Tafi","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl","key":"10.1016\/j.fertnstert.2017.07.1165_bib3","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.3122\/jabfm.17.suppl_1.S43","article-title":"Management of pelvic pain from dysmenorrhea or endometriosis","volume":"17","author":"Nasir","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1196\/annals.1434.007","article-title":"Endometriosis and infertility: epidemiology and evidence-based treatments","volume":"1127","author":"Ozkan","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/aje\/kwh275","article-title":"Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors","volume":"160","author":"Missmer","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.fertnstert.2012.05.031","article-title":"Endometriosis and infertility: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","article-title":"Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries","volume":"96","author":"Nnoaham","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/01674820400002279","article-title":"The impact of endometriosis upon quality of life: a qualitative analysis","volume":"25","author":"Jones","year":"2004","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/humupd\/dmp007","article-title":"Recurrence of endometriosis and its control","volume":"15","author":"Guo","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/deq302","article-title":"'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis","volume":"26","author":"Vercellini","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/AOG.0b013e3181758ec6","article-title":"Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery","volume":"111","author":"Shakiba","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib14","first-page":"1","article-title":"Safety of medical treatments for endometriosis","author":"Berlanda","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0010-7824(00)00182-7","article-title":"Menstruation: choosing whether\u2026 and when","volume":"62","author":"Kaunitz","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(99)11159-0","article-title":"Nuisance or natural and healthy: should monthly menstruation be optional for women?","volume":"355","author":"Thomas","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib18","first-page":"84","article-title":"ACOG updates guideline on diagnosis and treatment of endometriosis","volume":"83","author":"Armstrong","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.2.6085.487","article-title":"Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen","volume":"2","author":"Loudon","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2006.06.003","article-title":"Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bpobgyn.2007.08.004","article-title":"Continuous oral contraception: changing times","volume":"22","author":"Sulak","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib22","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2165\/00003495-200464210-00006","article-title":"Long-cycle treatment with oral contraceptives","volume":"64","author":"Wiegratz","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2005.09.009","article-title":"Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use","volume":"73","author":"Birtch","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib24","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jfprhc-2011-100213","article-title":"Contraceptive efficacy and tolerability of ethinylestradiol 20 mug\/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study","volume":"38","author":"Klipping","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jfprhc-2012-100397","article-title":"Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised phase III study","volume":"39","author":"Reif","year":"2013","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jfprhc-2011-100214","article-title":"Long-term tolerability of ethinylestradiol 20 mug\/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study","volume":"38","author":"Klipping","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jfprhc-2011-100225","article-title":"Efficacy of ethinylestradiol 20 mug\/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study","volume":"38","author":"Strowitzki","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1477-7525-8-138","article-title":"Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials","volume":"8","author":"Gerlinger","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJWH.S5633","article-title":"Dienogest in long-term treatment of endometriosis","volume":"3","author":"Schindler","year":"2011","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32526-9","article-title":"Canadian consensus guideline on continuous and extended hormonal contraception, 2007","volume":"29","author":"Guilbert","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajog.2015.08.074","article-title":"Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis","volume":"214","author":"Muzii","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"issue":"4 Suppl","key":"10.1016\/j.fertnstert.2017.07.1165_bib37","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"issue":"6 Suppl","key":"10.1016\/j.fertnstert.2017.07.1165_bib38","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"issue":"23 Suppl 1","key":"10.1016\/j.fertnstert.2017.07.1165_bib39","first-page":"I9","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib40","first-page":"E9","article-title":"A look at the long-term safety of an extended-regimen OC","volume":"59","author":"Davis","year":"2010","journal-title":"J Fam Pract"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib41","first-page":"235","article-title":"The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 \u03bcg\/levonorgestrel 100 \u03bcg + ethinyl estradiol 10 \u03bcg","volume":"2","author":"Krishnan","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2017.07.1165_bib42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2016.01.012","article-title":"Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives","volume":"93","author":"Dinger","year":"2016","journal-title":"Contraception"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217316916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217316916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T20:47:10Z","timestamp":1663966030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028217316916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0015028217316916"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.07.1165","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethinylestradiol 20\u00a0\u03bcg\/drospirenone 3\u00a0mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.07.1165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}